Women's Neutral Shoes (Click to see Men's Version)
Inventory for this style is limited and may sell out soon.
The effects of breast cancer are far-reaching. One in eight women will receive a cancer diagnosis in her lifetime. We're asking for your help in reaching a goal of zero more lives lost to this devastating disease. Throughout October, Mizuno and Fleet Feet Sports, with support from the Breast Cancer Research Foundation (BCRF), will unite to launch Project Zero, an initiative raising funds for breast cancer research.
As part of this initiative, Fleet Feet Sports will be the exclusive retailer of a men's and women's limited edition of the BCRF Wave Rider 21 -- the cornerstone running shoe from Mizuno that's once again been transformed. With redesigned Wave technology for softer cushioning and an enhanced responsive feel, the all-new Wave Rider 21 with Mizuno's DynamotionFit features a breakthrough in Dual Zone engineered mesh for breathability, movement and hold when it's needed most. For each pair sold of this limited-edition style, the BCRF will receive a donation of $10.
The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer by advancing the world's most promising research. The BCRF provides critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis, and survivorship. The BCRF is the highest-rated breast cancer organization in the U.S. with an A+ from Charity Watch and 4 out of 4 stars from Charity Navigator. 91% of all money goes to breast cancer research and awareness programs.